Patients with a fully magnetically levitated left ventricular assist device were followed up for 12 months in a randomized trial comparing placebo to aspirin with a vitamin K antagonist. The primary end point was evaluated at 12 months, and patients who continued receiving the treatment group medication were eligible for continued follow-up.
The probability of death or major hemocompatibility-related adverse event was lower in the placebo group compared to the aspirin group at both 12 and 24 months
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Willow bark may be the source of a new antiviral drugScientists have found that specially processed samples of willow bark extract have an antiviral effect which isn’t seen in already known medical compounds from willow bark, such as salicylic acid, the precursor to modern aspirin.
Source: NewsMedical - 🏆 19. / 71 Read more »
SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetesFindings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.
Source: NewsMedical - 🏆 19. / 71 Read more »